These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9619263)

  • 1. New opportunities for the development of cancer immunotherapies.
    Rosenberg SA
    Cancer J Sci Am; 1998 May; 4 Suppl 1():S1-4. PubMed ID: 9619263
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer.
    Rosenberg SA
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S2-7. PubMed ID: 10685650
    [No Abstract]   [Full Text] [Related]  

  • 3. Translation of cancer immunotherapies.
    Skipper J; Hoffman EW; O'Donnell-Tormey J; Old LJ
    Nat Med; 2004 Nov; 10(11):1154-5; author reply 1155. PubMed ID: 15516901
    [No Abstract]   [Full Text] [Related]  

  • 4. Translation of cancer immunotherapies.
    Mulé JJ; Weber JS
    Nat Med; 2004 Nov; 10(11):1153; author reply 1153-4. PubMed ID: 15516900
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cytotoxic T-cell immune response against melanoma antigens].
    Ayyoub M
    Ann Dermatol Venereol; 1998 Nov; 125 Suppl 2():S34-6. PubMed ID: 9922891
    [No Abstract]   [Full Text] [Related]  

  • 6. T cells take aim at cancer.
    Pardoll D
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15840-2. PubMed ID: 12461164
    [No Abstract]   [Full Text] [Related]  

  • 7. Melanoma, vitiligo, and uveitis.
    Albert DM
    Ophthalmology; 2010 Mar; 117(3):643-4; author reply 644. PubMed ID: 20189042
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress in human tumour immunology and immunotherapy.
    Rosenberg SA
    Nature; 2001 May; 411(6835):380-4. PubMed ID: 11357146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy and gene therapy of cancer.
    Rosenberg SA
    Cancer Res; 1991 Sep; 51(18 Suppl):5074s-5079s. PubMed ID: 1884383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New immunotherapy for patients with neoplasms using tumor antigens recognized by T lymphocytes].
    Kawakami Y
    Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2536-44. PubMed ID: 9922678
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody-interleukin 2 fusion proteins: a new approach to cancer therapy.
    Reisfeld RA; Gillies SD
    J Clin Lab Anal; 1996; 10(3):160-6. PubMed ID: 8731505
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer. Cancer immunotherapy is more than a numbers game.
    Offringa R
    Science; 2006 Oct; 314(5796):68-9. PubMed ID: 17023641
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer vaccines and immunotherapies: emerging perspectives.
    Henderson RA; Mossman S; Nairn N; Cheever MA
    Vaccine; 2005 Mar; 23(17-18):2359-62. PubMed ID: 15755628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphokine-activated killer lymphocytes: National Cancer Institute clinical trials.
    Clark J; Longo DL
    Immunol Ser; 1989; 48():37-58. PubMed ID: 2488325
    [No Abstract]   [Full Text] [Related]  

  • 15. Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration.
    Andersen MH; Gehl J; Reker S; Pedersen LØ; Becker JC; Geertsen P; thor Straten P
    Semin Cancer Biol; 2003 Dec; 13(6):449-59. PubMed ID: 15001164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the development of immunotherapy for the treatment of patients with cancer.
    Rosenberg SA
    J Intern Med; 2001 Dec; 250(6):462-75. PubMed ID: 11902815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer immunotherapy: breaking the barriers to harvest the crop.
    Pardoll D; Allison J
    Nat Med; 2004 Sep; 10(9):887-92. PubMed ID: 15340404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell receptor beta variable region diversity in melanoma metastases after interleukin 2-based immunotherapy.
    Willhauck M; Möhler T; Scheibenbogen C; Pawlita M; Brossart P; Schmier JW; Keilholz U
    Clin Cancer Res; 1996 Apr; 2(4):767-72. PubMed ID: 9816229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cell therapy in solid tumors].
    Ravaud A
    Bull Cancer; 2001 Jan; 88(1):91-100. PubMed ID: 11182658
    [No Abstract]   [Full Text] [Related]  

  • 20. New concepts in tumor antigens: their significance in future immunotherapies for tumors.
    Yang F; Yang XF
    Cell Mol Immunol; 2005 Oct; 2(5):331-41. PubMed ID: 16368059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.